By Professor Alison Ritter

Journal articles

Stirling R; Nathan S; Ritter A, 2023, 'Prioritizing measures to assess performance of drug treatment services: a Delphi process with funders, treatment providers and service-users', Addiction, 118, pp. 119 - 127, http://dx.doi.org/10.1111/add.16038

McLauchlan L; Lancaster K; Kearnes M; Mellor R; Ritter A, 2022, '“It's professional but it's personal”: Participation, personal connection, and sustained disagreement in drug policy reform', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103903

Mellor R; Kearnes M; Lancaster K; McLauchlan L; Ritter A, 2022, 'Established Tables and Emergent Huddles: Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19', Contemporary Drug Problems, 49, pp. 385 - 404, http://dx.doi.org/10.1177/00914509221123001

Barrett L; Mellor R; Ritter A; McLauchlan L; Kearnes M, 2022, 'Navigating the grey: Experiences of incremental cannabis reform in Australia', Drug and Alcohol Review, 41, pp. 1621 - 1629, http://dx.doi.org/10.1111/dar.13518

Ritter A, 2022, 'Words matter: A commentary on the new UK drug strategy', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103846

Vuong T; Gillies M; Larney S; Montebello M; Ritter A, 2022, 'The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls', Addiction, 117, pp. 1589 - 1597, http://dx.doi.org/10.1111/add.15755

O'Reilly K; Kowalski M; Barratt MJ; Ritter A, 2022, 'Distinguishing personal use of drugs from drug supply: Approaches and challenges', International Journal of Drug Policy, 103, pp. 103653, http://dx.doi.org/10.1016/j.drugpo.2022.103653

Curchin K; Weight T; Ritter A, 2022, 'Moral framings in the Australian parliamentary debate on drug testing of welfare recipients', Social Policy and Administration, 56, pp. 409 - 422, http://dx.doi.org/10.1111/spol.12774

Ritter A; van de Ven K; Vuong T; Chalmers J; Dobbins T; Livingston M; Berends L, 2022, 'Are market mechanisms associated with alcohol and other drug treatment outcomes?', Addiction, 117, pp. 1105 - 1116, http://dx.doi.org/10.1111/add.15681

Greer A; Bonn M; Shane C; Stevens A; Tousenard N; Ritter A, 2022, 'The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use', International Journal of Drug Policy, 102, pp. 103605, http://dx.doi.org/10.1016/j.drugpo.2022.103605

Sommerville K; Ritter A; Stephenson N, 2022, 'Pill testing policy: A comparative analysis using the Advocacy Coalition Framework', Drug and Alcohol Review, 41, pp. 275 - 284, http://dx.doi.org/10.1111/dar.13352

Conigrave KM; Ali RL; Armstrong R; Chikritzhs TN; d’Abbs P; Harris MF; Hewlett N; Livingston M; Lubman DI; McKenzie A; O’Leary C; Ritter A; Wilson S; Grimmond M; Banks E, 2021, 'Revision of the Australian guidelines to reduce health risks from drinking alcohol', Medical Journal of Australia, 215, pp. 518 - 524, http://dx.doi.org/10.5694/mja2.51336

Riordan BC; Winter DT; Barrett L; Ritter A; Lancaster K; Seear K; Butler K; Haber PS, 2021, 'Guidelines for the treatment of alcohol problems: an introduction', MEDICAL JOURNAL OF AUSTRALIA, 215, pp. S3 - S5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000703210100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC, 2021, 'New Australian guidelines for the treatment of alcohol problems: an overview of recommendations', Medical Journal of Australia, 215, pp. S3 - S32, http://dx.doi.org/10.5694/mja2.51254

Wilkinson C; Ritter A, 2021, 'Applying a ‘harm to others’ research framework to illicit drugs: political discourses and ambiguous policy implications', Addiction, 116, pp. 1941 - 1946, http://dx.doi.org/10.1111/add.15243

Wilkinson C; Ritter A, 2021, 'Thinking beyond the individual, a response to commentaries', Addiction, 116, pp. 1952 - 1953, http://dx.doi.org/10.1111/add.15605

Mellor R; Lancaster K; Ritter A, 2021, 'Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis', Addiction, 116, pp. 1413 - 1423, http://dx.doi.org/10.1111/add.15288

Mellor R; Lancaster K; Ritter A, 2021, 'Examining untreated and treated alcohol problem resolution in an Australian online survey sample', Drug and Alcohol Review, 40, pp. 1037 - 1046, http://dx.doi.org/10.1111/dar.13257

Vuong T; Ritter A; Shanahan M; Ali R; Nguyen N; Minh KP, 2021, 'Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam', Drug and Alcohol Review, 40, pp. 296 - 306, http://dx.doi.org/10.1111/dar.13176

van de Ven K; Ritter A; Vuong T; Livingston M; Berends L; Chalmers J; Dobbins T, 2021, 'A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providers', Journal of Substance Abuse Treatment, 132, pp. 108467, http://dx.doi.org/10.1016/j.jsat.2021.108467

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

Ritter A, 2021, 'Mental Health Ontologies: How We Talk About Mental Health, and Why it Matters in the Digital Age Janna Hastings, Exeter, UK: University of Exeter Press, 2020. ISBN 9781905816576', Addiction, 116, pp. 2248 - 2249, http://dx.doi.org/10.1111/add.15418

Stirling R; Ritter A; Rawstorne P; Nathan S, 2020, 'Contracting treatment services in Australia: Do measures adhere to best practice?', International Journal of Drug Policy, 86, pp. 102947, http://dx.doi.org/10.1016/j.drugpo.2020.102947

Nielsen S; Picco L; Kowalski M; Sanfilippo P; Wood P; Larney S; Bruno R; Ritter A, 2020, 'Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study', Research in Social and Administrative Pharmacy, 16, pp. 1694 - 1701, http://dx.doi.org/10.1016/j.sapharm.2020.02.009

O'Reilly MJA; Hughes CE; Bright DA; Ritter A, 2020, 'Structural and functional changes in an Australian high-level drug trafficking network after exposure to supply changes', International Journal of Drug Policy, 84, pp. 102797, http://dx.doi.org/10.1016/j.drugpo.2020.102797

Hughes C; Hulme S; Ritter A, 2020, 'The relationship between drug price and purity and population level harm', Trends and Issues in Crime and Criminal Justice, pp. 1 - 26

Cox S; Moss AC; Ritter A, 2020, 'Editorial for special issue: Vulnerable groups: Addiction research, policy and practice', Addictive Behaviors, 104, pp. 106266, http://dx.doi.org/10.1016/j.addbeh.2019.106266

Shanahan M; Seddon J; Ritter A; De Abreu Lourenco R, 2020, 'Valuing families' preferences for drug treatment: a discrete choice experiment', Addiction, 115, pp. 690 - 699, http://dx.doi.org/10.1111/add.14816

O'Keefe D; Ritter A; Stoove M; Hughes C; Dietze P, 2020, 'Harm reduction programs and policy in Australia: Barriers and enablers to effective implementation', Sucht, 66, pp. 33 - 43, http://dx.doi.org/10.1024/0939-5911/a000641

Mellor R; Ritter A, 2020, 'Redressing responses to the treatment gap for people with alcohol problems: The overlooked role of untreated remission from alcohol problems', Sucht, 66, pp. 21 - 30, http://dx.doi.org/10.1024/0939-5911/a000640

Rhodes T; Ritter A, 2020, 'Editing the International Journal of Drug Policy', International Journal of Drug Policy, 76, pp. 102664, http://dx.doi.org/10.1016/j.drugpo.2020.102664

van de Ven K; Ritter A; Berends L; Chalmers J; Lancaster K, 2020, 'Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment', Drug and Alcohol Review, 39, pp. 189 - 197, http://dx.doi.org/10.1111/dar.13027

van de Ven K; Ritter A; Roche A, 2020, 'Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field', Drugs: Education, Prevention and Policy, 27, pp. 1 - 14, http://dx.doi.org/10.1080/09687637.2019.1622649

Ritter A, 2020, 'Making drug policy in summer—drug checking in Australia as providing more heat than light', Drug and Alcohol Review, 39, pp. 12 - 20, http://dx.doi.org/10.1111/dar.13018

Greer A; Ritter A, 2020, 'The legal regulation of drugs and role of government: Perspectives from people who use drugs', Drug and Alcohol Dependence, 206, pp. 107737, http://dx.doi.org/10.1016/j.drugalcdep.2019.107737

Greer A; Ritter A, 2019, 'Harm reduction and the opioid crisis: Emerging policy challenges', International Journal of Drug Policy, 71, pp. 139 - 141, http://dx.doi.org/10.1016/j.drugpo.2019.05.015

Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O, 2019, 'Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine', Drugs, 79, pp. 1395 - 1418, http://dx.doi.org/10.1007/s40265-019-01154-5

Mellor R; Lancaster K; Ritter A, 2019, 'Systematic review of untreated remission from alcohol problems: Estimation lies in the eye of the beholder', Journal of Substance Abuse Treatment, 102, pp. 60 - 72, http://dx.doi.org/10.1016/j.jsat.2019.04.004

Lancaster K; Rhodes T; valentine K; Ritter A, 2019, 'A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy', Current Opinion in Environmental Science and Health, 9, pp. 85 - 90, http://dx.doi.org/10.1016/j.coesh.2019.06.006

Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M, 2019, 'Drug consumption rooms: A systematic review of evaluation methodologies', Drug and Alcohol Review, 38, pp. 406 - 422, http://dx.doi.org/10.1111/dar.12919

Greer AM; Ritter A, 2019, '“It's about bloody time”: Perceptions of people who use drugs regarding drug law reform', International Journal of Drug Policy, 64, pp. 40 - 46, http://dx.doi.org/10.1016/j.drugpo.2018.12.006

Ritter A; van de Ven K, 2019, 'Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?', Drug and Alcohol Review, 38, pp. 119 - 122, http://dx.doi.org/10.1111/dar.12871

Ritter A; van de Ven K, 2019, 'Is health or social welfare the right question? Response to commentaries', Drug and Alcohol Review, 38, pp. 129 - 130, http://dx.doi.org/10.1111/dar.12900

Ritter A; Mellor R; Chalmers J; Sunderland M; Lancaster K, 2019, 'Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand', Journal of Studies on Alcohol and Drugs, Sup 18, pp. 22 - 30, http://dx.doi.org/10.15288/jsads.2019.s18.22

Ritter A; Chalmers J; Gomez M, 2019, 'Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model', Journal of studies on alcohol and drugs. Supplement, Sup 18, pp. 42 - 50, http://dx.doi.org/10.15288/jsads.2019.s18.42

Lancaster K; Ritter A; valentine K; Rhodes T, 2019, '"A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy', International Journal of Drug Policy, 63, pp. 47 - 55, http://dx.doi.org/10.1016/j.drugpo.2018.10.011

Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'Quantifying the societal cost of methamphetamine use to Australia', International Journal of Drug Policy, 62, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.08.015

Lancaster K; Ritter A; Diprose R, 2018, 'Recasting Participation in Drug Policy', Contemporary Drug Problems, 45, pp. 351 - 365, http://dx.doi.org/10.1177/0091450918776024

Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A, 2018, 'Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.', Res Social Adm Pharm, http://dx.doi.org/10.1016/j.sapharm.2018.10.024

Ritter A; Hughes CE; Lancaster K; Hoppe R, 2018, 'Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy', Addiction, 113, pp. 1539 - 1547, http://dx.doi.org/10.1111/add.14197

Back to profile page